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ABSTRACT 
DeBoodt, Jennifer L., Audiology Doctoral Project, University of South Florida, 
December, 2003. Treatment of benign paroxysmal positional vertigo: Necessity 
of post-maneuver prohibition 
 
Benign paroxysmal positional vertigo (BPPV), characterized by a history of 
brief attacks of intense positional vertigo and rotary nystagmus, results from 
otoconial migration into the semicircular canals, making the sensory structures in 
the canal gravity sensitive.  Treatment methods include positioning maneuvers, 
which return the otoconia back into the otolith, and typically include a variety of 
activity limitations for the subsequent 24-48 hours.  Previous studies suggest 
BPPV treatment can be successful without any limitations of the patient post- 
therapy.  The purpose of this study was to determine the necessity of post-
maneuver restrictions on BPPV patients treated with the Canalith Repositioning 
Maneuver.  Twenty participants were identified as having BPPV of the posterior 
canal and treated with the Canalith Repositioning Maneuver. During post-
maneuver instruction, the ten participants assigned to the restricted group were 
provided with typical instructions.  Ten participants assigned to the non-restricted 
group were given no post-maneuver restrictions.  At the one-week post-treatment 
follow-up, all patients were free of vertigo and/or nystagmus. Results indicated 
that given two groups of subjects matched for age, gender, and symptoms, post-
maneuver restrictions are not necessary for successful outcome using the CRM 
to treat posterior-canal BPPV.   
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INTRODUCTION 
Benign paroxysmal positional vertigo (BPPV) is characterized by a history 
of brief attacks of intense positional vertigo and rotary nystagmus. It is reported 
to be the most common manifestation of vertigo in patients with vestibular 
disorders (Gans, 2000). Schuknecht (1962) was the first to describe the temporal 
bones of patients with BPPV symptoms. He reported the presence of calcium 
carbonate crystal deposits, (i.e. otoconia), adhering to the gelatinous cupula 
located in the ampulla of the posterior semicircular canal of symptomatic patients 
(Dornhoffer & Colvin, 2000). Over 90% of BPPV cases involve this canal (Gans, 
2000). This is due to the anatomical position of the canal as inferior to the otolith 
organs, causing the posterior semicircular canal to serve as a reservoir for the 
debris.  Today, this condition is known as cupulolithiasis, or BPPV of the cupula 
(Herdman & Tusa, 1996).  Schuknecht (1969) theorized that the otoconia detach 
themselves from the otolith by spontaneous degeneration or head trauma. The 
particles then travel toward and attach to the cupula. 
In addition to cupulolithiasis, Hall (1979) later postulated that the otoconia 
may not only adhere to the cupula, but may also become dislodged and present 
as freely floating debris in the posterior canal. The debris would make the canal 
sensitive to gravity. This condition is known canalithiasis (Fung & Hall, 1996). 
Cupulolithiasis is believed to account for only a small portion of all BPPV cases 
(5%), while canalithiasis is thought to be responsible for the majority (95%) 
(Gans, 2000). 
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Despite the potential for different pathological processes responsible for 
BPPV, all patients report a similar combination of symptoms. The most prevalent 
complaint is intense vertigo. The patient reports a sensation of spinning or falling 
associated with change in head position. Onset of this sensation is from one to 
ten seconds, and the symptoms will be transient, persisting less than one minute. 
The duration of symptoms may seem longer to the patient due to the extreme 
disorientation (Gans, 2000).  The most common form of BPPV, posterior canal 
BPPV (PC-BPPV), will present with upward beating rotary torsional nystagmus 
that beats toward the undermost ear (Nunez, Cass, &Furman, 2000). There is 
also a fatigability of these symptoms for canalithiasis that is not found for 
cupulolithiasis (Hall, 1979). The patient will most likely be able to isolate the 
affected ear, as certain common head and body positions involving the affected 
ear will provoke symptoms. The patient may present with no other audiological 
symptoms or complaints, as BPPV can occur in isolation from other pathologies. 
However, BPPV may occur secondary to pre-existing conditions and must be 
separated from these through case history report and a complete diagnostic 
evaluation (Herdman, Blatt, & Schubert, 2000). In younger patients, BPPV is 
often associated with a history of Meniere’s Disease, vestibular neuritis or 
labyrinthitis (Dornhoffer & Colvin, 2000).  
There is no pharmacological treatment for BPPV, and vestibular 
suppressants only provide temporary relief from the associated nausea. Over the 
years, exercise protocols have been designed to ameliorate symptoms. 
However, many of these treatments did not take into consideration the canal that 
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was involved nor did they differentiate between canalithiasis and cupulolithiasis. 
It was not until the work of Epley (1980), of Semont (1988), and of Parnes and 
Price-Jones (1993), that these maneuvers were defined for a high success rate. 
The Semont Liberatory Maneuver (Semont, 1988) is a successful treatment 
method for cupulolithiasis or canalithiasis. It requires movement of the patient in 
mass; involving a series of briskly performed position changes and requiring a 
good degree of patient mobility. It is contraindicated for those patients with recent 
hip replacements or hip fractures (Gans, 2000).  
The Canalith Repositioning Maneuver (CRM), as described by Epley 
(1980) and Parnes and Price-Jones (1993) is also a successful method of 
treating cupulolithiasis or canalithiasis. It is often more comfortable for patients 
and tends to be the preferred method of treatment. This maneuver requires only 
nominal movement of the patient, involving head movement and rolling to one 
side. Consequently, any physical limitations of the patient are less likely a factor 
in this treatment method, providing maximum comfort for the clinician and patient 
(Epley, 1992). However, some research suggests this method necessitates 
multiple maneuvers to cure symptoms, which is in contrast to the Semont 
Liberatory Maneuver (Nuti, Nati, & Passali, 2000). Nevertheless, Nunez, Cass 
and Furman (2000) report complete resolution of symptoms in over 91% of 
patients after only 1 or 2 treatment sessions of the CRM.  Although some 
patients require multiple treatments for absolute relief of symptoms, both of these 
maneuvers have been found to have a success rate of greater than 90% after 
two treatments (Gans, 2000; Nunez, Cass, &Furman, 2000).   
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Part of the treatment protocol for BPPV includes post-maneuver 
prohibitions. An extensive variety of patient limitations is recommended and 
utilized to prevent the loose debris from returning to the semicircular canals 
following treatment.  Such instructions may include remaining supine, keeping 
the head erect, sleeping at a 45º angle, refraining from lying on the pathologic 
side, and even wearing a cervical collar to prevent head movements (Nuti, Natu, 
& Passali, 2000).  Frequently, patients are instructed to abide by these 
restrictions 24 - 48 hours or even up to a week following treatment. Though the 
intent of post-maneuver prohibitions seems valid, such extensive restrictions may 
not be feasible. In some instances, due to patient neck size, utilization of a 
cervical collar may not even be possible. Further, there is evidence that these 
limitations may not even be necessary.  
Zucca, Valli, Valli, Perin, & Mira (1998) provided a new theory regarding 
resolution of BPPV symptoms. They postulated that dissolution of otoconia in 
endolymphatic fluid was a result of calcium ion content of the fluid. When 
studying the otolith debris of frogs, they found that, when calcium levels were 
high, it took longer for the calcium carbonate crystals to dissolve. Under normal 
circumstances, Zucca et al. (1998) discovered that the material would dissolve 
completely in the calcium deficient endolymph in less than 24 hours. This is 
corroborated by a study conducted by Nuti et al. (2000), who treated 52 BPPV 
patients using the Semont Liberatory Maneuver, giving no post-maneuver 
restrictions. All patients were free of symptoms, suggesting the otoconia debris 
did not re-enter the canals, regardless of patient activity or movement. This study 
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suggests that BPPV treatment can be successful without any limitations of the 
patient post-therapy. This is important because it would allow immediate 
resumption of normal daily life activities for a once debilitated patient.  
Given that the Canalith Repositioning Maneuver is often the preferred 
method of treatment of BPPV (attributed to its comfort and ease of 
administration), it is of particular interest to establish if results similar to Nuti et al. 
(2000) would be found using this treatment method. Therefore, the purpose of 
this study was to determine the necessity of post-maneuver restrictions on BPPV 
patients treated with the Canalith Repositioning Maneuver.  Specifically, this 
study addressed the question of whether treatment efficacy is affected in two 
groups of BPPV patients, one group given typical post-maneuver activity 
limitations and the other group given no restrictions. 
METHODS 
Participants 
All participants were patients referred to The American Institute of Balance 
(AIB) in Seminole, Florida, for vestibular function testing. Participants were 
included in the study if they had a diagnosis of posterior canal BPPV. Diagnosis 
was made via case history reports and a positive, modified Dix-Hallpike test 
during the vestibular evaluation. The Dix-Hallpike test was considered positive if 
there was presence of paroxysmal, up-beating rotary nystagmus toward the 
affected ear upon administration of the maneuver. Other classic findings to 
identify BPPV also had to be present and included an onset latency following 
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positioning with associated subjective vertigo. Any patients with bilateral, 
horizontal, or anterior canal BPPV were excluded from the study.   
Twenty patients meeting these criteria were assigned to one of two 
groups, the group receiving typical post-maneuver restrictions and the group 
receiving no restrictions. Subject groups were matched for age and gender. 
Specific details about the subject groups are shown in Table 1. The restricted 
group ranged in age from 30 – 88 years (mean:  67.6) and consisted of 6 women 
and 4 men.  The non-restricted group ranged in age from 50 - 83 years (mean:  
67.8) and also consisted of 6 women and 4 men. The involved ear was the right 
in most cases and the two groups were very similar on this parameter as well. 
Six participants in the restricted group had a history of prior episodes of BPPV, 
while four participants in the non-restricted group had this characteristic.   It was 
extremely important that both groups have similar presentation of symptoms so 
that any differences in treatment outcome could be attributed to presence or 
absence of post-maneuver restrictions. For this reason, onset latency, duration 
and subjective intensity of nystagmus were analyzed for both groups of 
participants during treatment.  
Table 1. Participant characteristics are shown for each group. 
FACTOR RESTRICTED GROUP NON-RESTRICTED GROUP
Age 67.6 67.8 
Male 4 4 
Female 6 6 
Affected Ear   
Right 8 7 
Left 2 3 
Prior BPPV Episode 6 4 
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Instrumentation 
  Patient eye movement during diagnosis or confirmation of BPPV was 
recorded via Synapsys video goggles, comprised of a modified Bolle mask fitted 
with binocular dual recording cameras. Recordings were transmitted via a Black 
and White Quad Processor, high resolution and real time, and recorded by a 
General Electric VHS Advances Video System, Model 13TVR72. Clinician and 
patient movement were also recorded via scenic camera JVC Videomovie 
compact VHS recorder, Model GR-AX808.     
Procedures 
All participants were identified or confirmed as having BPPV following the 
standard assessment protocol at AIB, or by its affiliated ENT physicians. This 
protocol included case history, audiological and VNG testing. A modified Dix-
Hallpike was administered for all patients prior to treatment.  Once the presence 
of PC-BPPV was confirmed, the patient returned within one week for treatment 
with the Canalith Repositioning Maneuver. All treatments were performed by one 
of two experienced audiologists, regardless of experimental group. 
The Canalith Repositioning Maneuver was similar to that utilized by Fung 
and Hall (1996) and described by Gans (2002). See Figure 1 for a schematic of 
each position.  In position one of the CRM, the participant’s symptoms and 
vertigo were provoked. This position was identical to that of the positioning of the 
patient during the Dix- Hallpike test.  The patient was positioned supine, with the 
neck hyper-extended and the affected ear down. The clinician supported the 
head and neck.  The patient was kept in that position for three minutes to allow  
Jennifer L. DeBoodt 
 10
the otoconia to move distal to the ampulla. In position two, the head was rotated 
toward the opposite ear with the head remaining positioned upward for three 
minutes. This allowed the otoconia material to settle at the common crus. In the 
third position, the patient was rolled onto his/her side for three minutes during 
Figure 1 
 
patient was seated upright. Following treatment with the CRM, the patient was 
rechecked with a Dix-Hallpike. This was performed to differentially diagnose the 
presence of canalithiasis versus cupulolithiasis based on fatigability of 
symptoms, as well as to test for successful clearance of the debris.  
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During post-maneuver instruction, the restricted group was provided a 
standard cervical collar, along with written and verbal instructions including the 
following: 1) avoid bending over or any inverting of the head for the next 24 
hours; 2) sleep semi-inclined at an angle of approximately 30º the first night; and 
3) avoid sleeping on the affected side for the next three to four nights. The non-
restricted group was given no post-maneuver restrictions.  
All patients returned one week following the initial treatment and the 
modified Dix-Hallpike was re-administered and patient report provided. Patients 
were also tested in the side-lying position to check for horizontal canal migration 
of the otoconia debris. During the side-lying procedure, the patient is laid on his 
or her side, with the head parallel to the ground.  It is then that symptoms 
associated with horizontal canal BPPV (HC-BPPV) present. Symptoms of HC-
BPPV include intense vertigo and horizontal nystagmus in the direction of the 
affected ear.  Checking for this is necessary as migration of otoconia debris to 
the horizontal canal frequently occurs during treatment for PC-BPPV. It is also 
possible that horizontal canal BPPV is present and masked by symptoms of the 
PC-BPPV in some cases.   
If no symptoms were present or evoked, the patient no longer needed to 
be seen. If symptoms persisted, the maneuver was repeated and the participant, 
regardless of group, was given post-maneuver restrictions and seen again in one 
week.  
Patients also provided a subjective report to complete the Provoked 
Vertigo Test (Smith-Wheelock, Shepard, & Telian, 1991) during each position of 
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the treatment, and then again at follow-up during re-check.  The Provoked 
Vertigo Test, which was adapted from the University of Michigan Vestibular 
Testing Center Habituation training flow sheet, was used to assess symptom 
duration and intensity of subjective vertigo. The examiner, via video-oculography, 
also determined presence or absence of nystagmus. 
RESULTS 
A one-way Analysis-of-Variance (ANOVA) with the factor group indicated 
so significant difference in age between the two groups [F(1,18)=0.001, p=0.97]. 
The data from subjective report used to complete the Provoked Vertigo Test 
were averaged and examined for trends using the factors of nystagmus onset 
latency, nystagmus duration, and intensity rating. This analysis was necessary to 
ensure that both participant groups had similar presentation of symptoms before 
and during treatment. In that way, any group differences observed at the follow-
up appointment should be attributed to post-maneuver restrictions given that was 
the only factor on which the subjects differed. Data were collected on these 
factors for each of the three positions of the CRP treatment.  
Onset latency of nystagmus is shown for both groups as a function of 
treatment position in Figure 2. All patients in this study presented with nystagmus 
in position one of the maneuver.  Onset latency for the restricted group ranged 
from 1 to 9 s (average = 3.3). Data for the unrestricted group ranged from 0 to 9 s 
(average = 3.4). For position two, only three subjects experienced nystagmus, 
and each of these were in the restricted group.  Average onset was 1.1 s, while 
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Figure 2. Nystagmus onset latency during the three treatment positions is shown 
for each group. 
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Figure 3. Nystagmus duration during the three treatment positions is shown for 
each group.
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the unrestricted group had no nystagmus present.  For position three, only two 
patients in the restricted group and one in the non-restricted group experienced 
nystagmus. Onset latencies of 0.2 s were obtained for both groups.  
These data were analyzed with a two-way ANOVA with one between 
subjects factor (group) and one within subjects factor (position). Results indicated 
a significant effect of position [F(2,17)=13.69, p<0.001].  There was no effect of 
group [F(1,18)=0.50, p=0.49] and no interaction [F(2,17)=1.71, p=0.21]. Post-hoc 
testing (Tukey) indicated that onset latency of Position 1 was significantly longer 
than for Position 2 or Position 3 (p<0.05), but there was no difference in onset 
latency between Position 2 and Position 3 (p>0.05). These results indicated that 
onset latency of nystagmus decreased from the first position to the second, but 
no further decrease was observed. 
Duration of nystagmus is shown for each group and each position in 
Figure 3.   Duration of nystagmus for the restricted group ranged from 2 to 19 s 
(average = 10.9). Data for the unrestricted group ranged from 5 to 19 s (average 
= 11.6).  For position two, of the three subjects in the restricted group who 
experienced nystagmus, average duration was 2.3 s.  Again, the unrestricted 
group had no nystagmus present.  For position three, only two participants in the 
restricted group and the one participant in the non-restricted group experienced  
nystagmus. Average duration was 2.6 s for the restricted group with a 1.3 s 
duration for the subject in the non-restricted group.  
These data were also analyzed with a two-way ANOVA with one between 
subjects factor (group) and one within subjects factor (position). Results indicated 
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a significant effect of position [F(2,17)=54.03, p< 0.001].  There was no effect of 
group [F(1,18)=0.52, p=0.48] and no interaction [F(2,17)=1.04, p=0.38]. Post-hoc 
testing (Tukey) indicated that the duration of the nystagmus elicited with Position 
1 was significantly longer than the nystagmus durations elicited by Positions 2 or 
3 (p<0.05), but there was no difference in duration between Position 2 and 
Position 3 (p>0.05). These results indicated that duration of nystagmus 
decreased from the first position to the second, but no further decrease was 
observed. 
Finally, each subject was asked to rate the intensity of the vertigo during 
each position of treatment from 0 to 10. A rating of 0 indicated no subjective 
vertigo and a rating of 10 indicated the greatest magnitude of vertigo.  These 
intensity ratings are summarized as a function of treatment position in Figure 4 
for both groups.  Intensity ratings in position one for the restricted group ranged 
from 1 to 10 (average = 6.7). Ratings for the unrestricted group ranged from 3 to 
10 (average = 5.5).  For position two, the restricted group subjectively rated the 
intensity of vertigo from 0 to 8 (average 2.3). None of the participants in the 
unrestricted group experienced vertigo for this position.  For position three, the 
restricted group ratings ranged from 0 to 8 (average1.5) and for the non-
restricted group 0 to 7 (average 1.4). 
 As for onset latency and duration of nystagmus, the intensity rating data 
were also analyzed with a two-way ANOVA with one between subjects factor  
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Figure 4. Nystagmus intensity rating is shown during the three treatment 
positions for each group. 
 
(group) and one within subjects factor (position). Results indicated a significant 
effect of position [F(2,17)=44.72, p < .001].  There was no effect of group 
[F(1,18)=2.53, p=0.13] and no interaction [F(2,17)=0.45, p=0.65]. Post-hoc 
testing (Tukey) indicated that the intensity of the nystagmus elicited with Position 
1 was significantly greater than the intensity of the nystagmus elicited by 
Positions 2 or 3 (p<0.05), but there was no difference between Position 2 and 
Position 3 (p>0.05). These results indicated that the intensity of the nystagmus 
decreased from the first position to the second, but no further decrease was 
observed. 
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The data regarding onset latency, nystagmus duration, and nystagmus 
intensity indicate that both groups were equivalent on these factors following 
treatment. The groups were also equivalent in terms of gender and age. Any 
subsequent differences should be attributable to the use of restrictions. 
Following each treatment, all patients were immediately rechecked using 
the modified Dix-Hallpike to assure the treatment was effective in clearing all 
debris from the posterior canal.  Only one participant, who was assigned to the 
non-restricted group, continued to have symptoms following the initial treatment. 
This participant was re-treated using the CRM as described above with the one 
exception that the time interval that the patient remained in each position was 
reduced to only one minute. The remaining 19 subjects were without vertigo or 
nystagmus during the re-check immediately following the treatment.   
At the one-week post-treatment follow-up, all patients were free of vertigo 
and/or nystagmus when checked with the modified Dix-Hallpike. This 
demonstrated that the otoconia debris was successfully removed from the 
posterior canal in all cases.  However, side-lying positional testing indicated HC-
BPPV in two subjects who had been assigned to the restricted group.  One 
subject was a male and presented with a right horizontal canal BPPV and the 
second, a female subject with left horizontal canal BPPV.  It is believed that the 
male subject experienced a horizontal canal migration during treatment of the 
posterior-canal BPPV. During position one, the participant raised his head, which 
presumably allowed the otoconia to migrate to the right horizontal canal.  In the 
second case, it was suspected that the horizontal canal BPPV was present 
Jennifer L. DeBoodt 
 18
before initial treatment but was masked by the severity of the posterior canal 
nystagmus.    
DISCUSSION 
The Canalith Repositioning Maneuver has been used for many years as a 
method of successfully treating cupulolithiasis and canalithiasis (Cohen & 
Jerabek, 1999).  There are many variations and forms of this treatment, although 
each is based on the same underlying principle of moving the otolithic debris 
from the posterior semicircular canal to the utricle.  Many clinicians employ post-
maneuver restrictions following this treatment to ensure that the debris does not 
re-enter the canal. There is evidence that these restrictions are unnecessary for 
the Semont Liberatory Maneuver (Nuti, Nati, & Passali, 2000).  The purpose of 
this investigation was to determine if such restrictions are necessary for the CRM 
treatment procedure.  
Several factors were analyzed to ensure homogeneity of the two 
participant groups. Latency of nystagmus onset, nystagmus duration, and 
nystagmus intensity were all assessed for each treatment position.  One classic 
characteristic of BPPV is the presence of an onset latency of nystagmus of less 
than ten seconds after moving into the position before the nystagmus starts. The 
subjects involved in this study exhibited typical onset latencies during the 
treatment positions. 
Duration of nystagmus associated with BPPV is no longer than 30 
seconds.  Duration data from the subjects in this study were in agreement with 
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prior studies and averaged 3.35 sec.  Further, duration of nystagmus was longest 
during position one and decreased significantly by the second position.  
Finally, intensity of the vertigo was considered.  This was rated as 
strongest for position one and decreased significantly for the second position. 
There was no difference in intensity of vertigo for positions two and three.     
Given the similarity of the groups in terms of age and gender along with 
the fact that there was no difference between the two groups on any of the 
factors assessed during treatment, outcome following either post-maneuver 
restrictions or no restrictions should be the one influencing factor on results at 
follow-up. The presence of absence of symptoms was the factor that would 
determine the necessity of post-maneuver restrictions.  When each subject 
returned for follow-up and went through the diagnostic positioning, no subject 
presented with either nystagmus or subjective vertigo. This indicated successful 
treatment. Further, since none of the subjects from either group experienced 
BPPV symptoms during the diagnostic evaluation at the follow-up, it was 
interpreted that post-maneuver restrictions do not add to the success of the 
treatment. This finding is in agreement with the work of Nuti et al. (2000) in 
treating BPPV with the Semont Liberatory Maneuver.   
Nuti et al. (2000) studied the outcomes of 52 patients with BPPV who 
were treated with the SLM, all given no post-maneuver restrictions.  All patients 
were checked following treatment and forty-seven of the 52 subjects (94%) were 
free of symptoms. The authors interpreted this result as indicative of successful 
treatment using the SLM without activity limitations. The results of the current 
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study indicate that treatment is also successful for the CRM without the use of 
activity limitations.  
 As there was no effect of post-maneuver treatment restrictions, this may 
indicate that the success of the treatment is consistent with dissolution of 
otoconia in the utricle.  As reported by Zucca et al. (1998) otoconia debris is able 
to dissolve in the calcium deficient endolymph over time   As long as calcium 
levels are normal, dissolution time should be rapid and result in amelioration of 
physiological symptoms.  In other words, if the debris dissolves once returned to 
the utricle, it cannot be re-deposited into the canals. This occurs regardless of 
the presence or absence of post-maneuver restrictions.  The results observed in 
the current study appear to be consistent with the results of Zucca et al 1998). 
The CRM has been utilized for many years as an effective form of 
treatment for posterior canal BPPV.  The results reported here support the 
efficacy of this treatment. All subjects were clear of symptoms one week post-
treatment, which is slightly higher than the 90% reported in other studies.  
SUMMARY AND CONCLUSIONS 
The current study addressed the necessity of post-maneuver restrictions 
for BPPV patients treated with the Canalith Repositioning Maneuver.  The 
primary focus was whether treatment efficacy was affected in two groups of 
BPPV patients, one group given typical post-maneuver activity limitations and the 
other group given no restrictions.  Results indicated that given two groups of 
subjects matched for age, gender, and symptoms, post-maneuver restrictions are 
not necessary for successful outcome using the CRM to treat posterior-canal 
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BPPV. The significance of this finding is that patients may return to normal daily 
activities immediately following treatment. 
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